leading pharmaceutical glp-1 treatments WHO Treatments: WHO Endorses GLP-1 Drugs as Key to Combat Global Obesity Crisis, ETPharma the composition contains chromium polynicotinate GLP-1 Costs Explained: Managing Coverage

Nicholas Jacobus Key Takeaways Wegovy pill, the first oral GLP-1 for obesity, is now available in the U.S

While state Medicaid programs must cover nearly all Food and Drug Administration (FDA) approved drugs, a long-standing statutory exception allows states to choose whether to cover weight-loss drugs under Medicaid

Diabetes , 63 (10), 3346-3358

The nutritional strategy for GLP-1 therapy must go hand in hand with the medication, including proper injection technique and picking the right place to inject

Back Brandt, SJ, Mller, TD, DiMarchi, RD, et al (12 Sept 2018) 'Peptide-based multi-agonists: a new paradigm in metabolic pharmacology', Journal of Internal Medicine

But the fact that patients must take these drugs into perpetuity to maintain their effects makes the potential cost base quite large, especially given the large size of the total addressable market